DENISE POPPEN-SZYNAL: Open Payments
NPI 1528494655 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 43 payments from 14 companies in 2025. Trend: 2023 $1,309 · 2024 $1,263 · 2025 $902
Food & beverage: $857Education: $45
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $210 |
| Novo Nordisk Inc | 7 | $137 |
| Lilly USA, LLC | 4 | $128 |
| Otsuka America Pharmaceutical, Inc. | 4 | $110 |
| ABBVIE INC. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Inspire Medical Systems, Inc. | 1 | $46 |
| Exact Sciences Corporation | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
Products named: REPATHA, REXULTI, OTEZLA, MOUNJARO, JARDIANCE, UBRELVY, INSPIRE, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
